Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy

被引：0
|
作者：
Burcu Dogan
Izzet Hakki Arikan
Derya Guler
Nursen Keles
Banu Isbilen
Ferruh Isman
Aytekin Oguz
机构：
[1] Istanbul Medeniyet University,Department of Family Physicians
[2] Goztepe Training and Research Hospital,Department of Nephrology
[3] Marmara University Pendik Hospital,Department of Cardiology
[4] Istanbul Medeniyet University,Department of Clinical Chemistry
[5] Goztepe Training and Research Hospital,Department of Internal Medicine
[6] Istanbul Medeniyet University,undefined
[7] Goztepe Training and Research Hospital,undefined
[8] Istanbul Medeniyet University,undefined
[9] Goztepe Training and Research Hospital,undefined
来源：
International Urology and Nephrology | 2016年 / 48卷
关键词：
Type 1 diabetes mellitus; sKlotho; FGF-23; Cardiac function; Diabetic nephropathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：399 / 407
页数：8
相关论文
共 50 条
  • [31] Impact of sevelamer hydrochloride on fibroblast growth factor-23 levels in patients undergoing hemodialysis
    Ahmed, Fatma Abdelrahman
    Khalil, Amr
    Elsaid, Tamer
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2548 - I2548
  • [32] Impact of sevelamer hydrochloride on fibroblast growth factor-23 levels in patients undergoing hemodialysis
    Ahmed, Fatma Abdelrahman
    Khalil, Amr
    Elsaid, Tamer
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [33] Plasma levels of fibroblast growth factor-23 are associated with muscle mass in haemodialysis patients
    Fukasawa, Hirotaka
    Ishigaki, Sayaka
    Kinoshita-Katahashi, Naoko
    Niwa, Hiroki
    Yasuda, Hideo
    Kumagai, Hiromichi
    Furuya, Ryuichi
    NEPHROLOGY, 2014, 19 (12) : 784 - 790
  • [34] Fibroblast Growth Factor-23 importance as a prognostic factor in hemodialysis patients
    Al Atbee, Mohammed Younus Naji
    Hamu, Ali Hussein
    Hammoudi, Faten Abdulghani
    Allawi, Ali Abdulmajid Dyab
    Tuama, Hala Sami
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2023, 18 (09): : 423 - 431
  • [35] CHANGE IN FIBROBLAST GROWTH FACTOR-23 LEVELS DURING CONVENTIONAL HAEMODIALYSIS
    Damasiewicz, M.
    Kerr, P.
    Tesch, G.
    Polkinghorne, K.
    NEPHROLOGY, 2011, 16 : 30 - 31
  • [36] Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates
    Ali, Farah N.
    Josefson, Jami
    Mendez, Armando J.
    Mestan, Karen
    Wolf, Myles
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (04): : 1673 - 1679
  • [37] Fibroblast growth factor-23 in patients with homozygous familial hypercholesterolemia
    Zamparini, Jarrod M.
    Immelman, Andrew R.
    Raal, Frederick J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (03) : 767 - 772
  • [38] Prognostic Importance of Fibroblast Growth Factor-23 in Dialysis Patients
    Akalin, Nilgul
    Okuturlar, Yjldjz
    Harmankaya, Ozlem
    GedJkbasi, Asuman
    Sezjklj, Selcuk
    Yucel, Sibel Kocak
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2014, 2014
  • [39] Elevated vascular endothelial growth factor in type I diabetic patients with diabetic nephropathy
    Hovind, P
    Tarnow, L
    Ostergaard, PB
    Parving, HH
    DIABETOLOGIA, 1998, 41 : A318 - A318
  • [40] The emerging role of fibroblast growth factor 21 in diabetic nephropathy
    Mao, Song
    Ren, Xianguo
    Zhang, Jianhua
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2016, 36 (06) : 586 - 592
12345